Key Takeaways
- Epigral plans to double its wind-solar hybrid power capacity to 38.14 MW with a Rs 21.38 crore investment.
- The expansion will be executed in partnership with Prozeal Green Energy Ltd, formalized for 25 years.
- The new capacity is expected to meet rising energy demands by the fourth quarter of FY26.
Capacity Expansion Announcement
Specialty chemical manufacturer Epigral announced plans to significantly increase its renewable energy capacity by more than doubling its wind-solar hybrid power output from 18.34 MW to 38.14 MW. This expansion will be executed through a strategic investment of Rs 21.38 crore for a 26 percent stake in a special purpose vehicle (SPV) created in collaboration with Prozeal Green Energy Ltd.
The partnership aims to add 19.80 MW of renewable energy capacity through an energy subscription agreement and shareholder agreements that will last for 25 years. The commissioning of this new capacity is anticipated by the fourth quarter of FY26.
Epigral’s Chairman and Managing Director, Maulik Patel, emphasized the importance of this capacity expansion to meet the company’s increasing energy needs amid several ongoing projects. This enhancement aligns with the company’s broader strategy focusing on clean energy while aggressively advancing its growth in the specialty chemicals sector.
In addition to the renewable energy initiatives, Epigral has announced plans to boost production in its core chemical products. The company aims to increase CPVC resin production to 150,000 tonnes annually and epichlorohydrin (ECH) to 100,000 tonnes annually. Recently, Epigral also launched a chlorotoluene value chain plant at its facility in Dahej, Gujarat.
By investing in renewable energy, Epigral demonstrates its commitment to sustainability while positioning itself for future growth in a competitive market.
The content above is a summary. For more details, see the source article.
